Ho
Homology Med
Bedford MAFounded 201580 employees
Private CapbiotechAcquiredRare DiseaseHematology
Platform: HMI-102 AAVHSCs
Market Cap
N/A
All Drugs
4
Clinical Trials
9
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimacilimab | HOM-2954 | Phase 3 | 3 | USP1 | PompeALL | ||
| HOM-3477 | HOM-3477 | Approved | 2 | PSMA | MCLEoE | ||
| Talarasimod | HOM-7191 | Phase 3 | 2 | PI3Kα | ALLDLBCL | ||
| Rilulucimab | HOM-9740 | NDA/BLA | 2 | PI3Kα | Huntington'sCF |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (8)